|
RASGRP4 |
RAS guanyl releasing protein 4 |
- FCERI mediated NF-kB activation
- RAF/MAP kinase cascade
|
|
|
|
RASIP1 |
Ras interacting protein 1 |
|
|
|
|
RASSF2 |
Ras association domain family member 2 |
|
|
|
|
RASSF5 |
Ras association domain family member 5 |
|
|
|
|
RGL1 |
ral guanine nucleotide dissociation stimulator like 1 |
- PPARA activates gene expression
- RAF/MAP kinase cascade
|
|
|
|
RGL2 |
ral guanine nucleotide dissociation stimulator like 2 |
|
|
|
|
RGL4 |
ral guanine nucleotide dissociation stimulator like 4 |
|
|
|
|
RGS12 |
regulator of G protein signaling 12 |
- G alpha (i) signalling events
- G alpha (i) signalling events
|
|
|
|
RHOD |
ras homolog family member D |
- Rho GTPase cycle
- RHO GTPases Activate Formins
|
|
|
|
RIN1 |
Ras and Rab interactor 1 |
- RAB GEFs exchange GTP for GDP on RABs
|
|
|
|
RIT2 |
Ras like without CAAX 2 |
- Signalling to p38 via RIT and RIN
|
|
|
|
RNF115 |
ring finger protein 115 |
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
RSPO3 |
R-spondin 3 |
- Regulation of FZD by ubiquitination
- RUNX1 regulates transcription of genes involved in WNT signaling
|
|
|
|
SNRPE |
small nuclear ribonucleoprotein polypeptide E |
- SLBP independent Processing of Histone Pre-mRNAs
- snRNP Assembly
- mRNA Splicing - Major Pathway
- mRNA Splicing - Minor Pathway
- RNA Polymerase II Transcription Termination
- SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs
|
|
|
|
SNX14 |
sorting nexin 14 |
|
|
|
|
SNX17 |
sorting nexin 17 |
|
|
|
|
SOS2 |
SOS Ras/Rho guanine nucleotide exchange factor 2 |
- NRAGE signals death through JNK
- Rho GTPase cycle
- G alpha (12/13) signalling events
- Activation of RAC1
- Interleukin-15 signaling
|
|
|
|
SRC |
SRC proto-oncogene, non-receptor tyrosine kinase |
- Signaling by ERBB2
- Nuclear signaling by ERBB4
- Downregulation of ERBB4 signaling
- PIP3 activates AKT signaling
- GAB1 signalosome
- Downstream signal transduction
- Constitutive Signaling by Aberrant PI3K in Cancer
- Integrin signaling
- GRB2:SOS provides linkage to MAPK signaling for Integrins
- p130Cas linkage to MAPK signaling for integrins
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- DCC mediated attractive signaling
- DCC mediated attractive signaling
- Netrin mediated repulsion signals
- Regulation of commissural axon pathfinding by SLIT and ROBO
- RAF activation
- MAP2K and MAPK activation
- Signaling by moderate kinase activity BRAF mutants
- Signaling by high-kinase activity BRAF mutants
- Signaling by BRAF and RAF fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- MET activates PTK2 signaling
- InlA-mediated entry of Listeria monocytogenes into host cells
- Regulation of RUNX1 Expression and Activity
- RUNX2 regulates osteoblast differentiation
- Regulation of RUNX3 expression and activity
- Extra-nuclear estrogen signaling
- Activated NTRK2 signals through FYN
- Activated NTRK3 signals through PI3K
- Activated NTRK3 signals through PI3K
- Long-term potentiation
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
|
- Dasatinib
- RU84687
- RU79256
- N6-Benzyl Adenosine-5'-Diphosphate
- RU85493
- RU78262
- Phosphonotyrosine
- Malonic acid
- RU83876
- RU90395
- RU79072
- RU78783
- 1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine
- PASBN
- 2-[4-[(Z)-2-Acetamido-3-oxo-3-[[(3S)-2-oxo-1-[(4-phenylphenyl)methyl]azepan-3-yl]amino]prop-1-enyl]-2-formylphenyl]acetic acid
- PAS219
- DPI59
- RU82197
- Phenylphosphate
- RU78300
- RU79073
- RU82209
- ISO24
- RU85053
- RU78299
- Oxalic Acid
- RU78191
- Citric acid
- Paratoulene phosphate
- 4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE
- Purvalanol A
- XL228
- Tirbanibulin
- Bosutinib
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea
- 1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea
- 3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL
- PD-168393
- [4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile
- PP-121
- 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
- 2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE
- N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE
- (2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide
- Ponatinib
- Nintedanib
- Fostamatinib
|
|
|
STK38 |
serine/threonine kinase 38 |
|
|
|
|
TIAM1 |
TIAM Rac1 associated GEF 1 |
- NRAGE signals death through JNK
- Rho GTPase cycle
- EPHB-mediated forward signaling
- EPH-ephrin mediated repulsion of cells
- G alpha (12/13) signalling events
- Activated NTRK2 signals through CDK5
|
|
|